These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 12634383)

  • 61. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prothymosin alpha associates with the oncoprotein SET and is involved in chromatin decondensation.
    Karetsou Z; Martic G; Tavoulari S; Christoforidis S; Wilm M; Gruss C; Papamarcaki T
    FEBS Lett; 2004 Nov; 577(3):496-500. PubMed ID: 15556635
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex.
    Peinado H; Ballestar E; Esteller M; Cano A
    Mol Cell Biol; 2004 Jan; 24(1):306-19. PubMed ID: 14673164
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block.
    Choudhuri T; Verma SC; Lan K; Murakami M; Robertson ES
    J Virol; 2007 Jun; 81(12):6718-30. PubMed ID: 17409144
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21.
    Radkov SA; Bain M; Farrell PJ; West M; Rowe M; Allday MJ
    J Virol; 1997 Nov; 71(11):8552-62. PubMed ID: 9343213
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.
    Morgan SM; Wilkinson GW; Floettmann E; Blake N; Rickinson AB
    J Virol; 1996 Apr; 70(4):2394-402. PubMed ID: 8642667
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway.
    Gain C; Malik S; Bhattacharjee S; Ghosh A; Robertson ES; Das BB; Saha A
    PLoS Pathog; 2020 Feb; 16(2):e1008105. PubMed ID: 32092124
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression.
    Laherty CD; Yang WM; Sun JM; Davie JR; Seto E; Eisenman RN
    Cell; 1997 May; 89(3):349-56. PubMed ID: 9150134
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
    Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Bristol JA; Ma S; Ranheim EA; Gumperz J; Johannsen EC; Kenney SC
    PLoS Pathog; 2018 Aug; 14(8):e1007221. PubMed ID: 30125329
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming.
    McClellan MJ; Wood CD; Ojeniyi O; Cooper TJ; Kanhere A; Arvey A; Webb HM; Palermo RD; Harth-Hertle ML; Kempkes B; Jenner RG; West MJ
    PLoS Pathog; 2013 Sep; 9(9):e1003636. PubMed ID: 24068937
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multiple N-CoR complexes contain distinct histone deacetylases.
    Jones PL; Sachs LM; Rouse N; Wade PA; Shi YB
    J Biol Chem; 2001 Mar; 276(12):8807-11. PubMed ID: 11254656
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
    Sekhavat A; Sun JM; Davie JR
    Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa.
    Robertson ES; Grossman S; Johannsen E; Miller C; Lin J; Tomkinson B; Kieff E
    J Virol; 1995 May; 69(5):3108-16. PubMed ID: 7707539
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression.
    Jha HC; A J MP; Saha A; Banerjee S; Lu J; Robertson ES
    J Virol; 2014 Apr; 88(7):3776-88. PubMed ID: 24429368
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C.
    Touitou R; Hickabottom M; Parker G; Crook T; Allday MJ
    J Virol; 2001 Aug; 75(16):7749-55. PubMed ID: 11462050
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth.
    Maruo S; Wu Y; Ito T; Kanda T; Kieff ED; Takada K
    Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4419-24. PubMed ID: 19237563
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
    Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB
    J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation.
    Shukla SK; Jha HC; El-Naccache DW; Robertson ES
    Oncotarget; 2016 Apr; 7(14):18116-34. PubMed ID: 26908453
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.
    Lin J; Johannsen E; Robertson E; Kieff E
    J Virol; 2002 Jan; 76(1):232-42. PubMed ID: 11739688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.